Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022

Rhea-AI Summary

Venus Concept (NASDAQ: VERO) will release its second quarter fiscal year 2022 financial results on August 12, 2022, before market opening. Management will hold a conference call at 8:00 a.m. ET on the same day to discuss the results, which will include a Q&A session. Participants can join via phone or a live webcast available on the investor relations website. Venus Concept is a leader in medical aesthetic technology, offering a subscription-based sales model and operates in over 60 countries with a diverse product portfolio.

Positive

• Strong global presence with operations in over 60 countries.
• Diverse product portfolio including minimally invasive and non-invasive technologies.
• Subscription-based sales model targeting North America and established global markets.

Negative

• None.

TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2022 financial results will be released before the market opens on Friday, August 12, 2022.

Management will host a conference call at 8:00 a.m. Eastern Time on August 12, 2022 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13731063. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13731063. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 18 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems include NeoGraft® and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

FAQ

When will Venus Concept release its second quarter 2022 financial results?

Venus Concept will release its second quarter fiscal year 2022 financial results on August 12, 2022.

What time is the conference call for Venus Concept's Q2 2022 results?

The conference call will be held at 8:00 a.m. Eastern Time on August 12, 2022.

How can I participate in the Venus Concept conference call?

You can participate by dialing 877-407-2991 or 201-389-0925 for international callers, using access code 13731063, or by joining the live webcast on their investor relations website.

Is there a replay available for the Venus Concept conference call?

Yes, a replay will be available for two weeks after the call using the same access code.